35,768
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

Characteristics and viral propagation properties of a new human diploid cell line, walvax-2, and its suitability as a candidate cell substrate for vaccine production

, , , , , , , & show all
Pages 998-1009 | Received 03 Nov 2014, Accepted 12 Dec 2014, Published online: 01 May 2015

References

  • Wahala WM, Silva AM. The human antibody response to dengue virus infection. Viruses 2011; 3 12:2374-95; PMID: 22355444; http://dx.doi.org/10.3390/v3122374
  • Ciupe SM, Ribeiro RM, Perelson AS. Antibody responses during hepatitis B viral infection. PLoS Comput Biol 2014; 10 7:e1003730; PMID: 25078553; http://dx.doi.org/10.1371/journal.pcbi.1003730
  • WHO study group on cell substrates for production of biologicals. WHO Headquarters, 2007; 11-12, Geneva, Switzerland
  • Zhang DL, Ji L, Li LJ, Huang GS. Systematically experimental investigation on carcinogenesis or tumorigenicity of VERO cell lines of different karyotypes in nude mice in vivo used for viral vaccine manufacture. Yi Chuan Xue Bao 2004; 31 7:647-60; PMID: 15473315
  • Pagano JS, Bottiger, M, Bonnevier, JO, Gard, S. The response and the lack of spread in swedish school children given an attenuated poliovirus vaccine prepared in a human diploid cell strain. Am J Hyg 1964; 79:74-85; PMID: 14114357
  • Fletcher MA, Hessel L, Plotkin SA. Human diploid cell strains (HDCS) viral vaccines. Dev Biol Stand 1998; 93 97-107; PMID: 9737384
  • Hayflick L. History of cell substrates used for human biological. Dev Biol Stand 1989; 70:11-26; PMID: 2668070
  • Jacobs JP, Jones CM, Baille JP. Characteristics of a human diploid cell designated MRC-5. Nature 1970; 227 5254:168-70; PMID: 4316953; http://dx.doi.org/10.1038/227168a0
  • Guo SH, Tao H, Ying ZF. Study on safety and immunogenicity of oral poliomyelitis attenuated live vaccine (human diploid cell). Zhongguo Yi Miao He Mian Yi 2010; 16 3:193-6; PMID:20726255
  • WHO. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. WHO Expert Committee on Biological Standardization Geneva, World Health Organization, In press (Adopted, 2010). 2010
  • Zhang K, Na T, Wang L, Gao Q, Yin W, Wang J, Yuan BZ. Human diploid MRC-5 cells exhibit several critical properties of human umbilical cord-derived mesenchymal stem cells. Vaccine 2014;32(50):6820-6827; PMID: 25086263
  • Yang E, Cheng C, Zhang Y, Wang J, Che Y, Pu J, Dong C, Liu L, He Z, Lu S, et al. Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line. Hum Vaccin Immunother 2014; 10(5):1266-1273; PMID:24583556; http://dx.doi.org/10.4161/hv.28083
  • Guo YZ, Zhou Y. The effects of environmental pollution on human chromosome instability. Proc Clinical Med J 2003; 12 12:912-3
  • von Seefried A, Chun JH. Serially subcultivated cells as substrates for poliovirus production for vaccine. Dev Biol Stand 1981; 47:25-33; PMID: 6262151
  • Leiva R. A brief history of human diploid cell strains. Natl Cathol Bioeth Q 2006; 6 3:443-51; PMID: 17091551; http://dx.doi.org/10.5840/ncbq20066328
  • World Health Organization. Rabies Vaccines. WHO Position Paper, Weekly Epidemiological Record, No. 85, 6th August 2010, Geneva, Switzerland
  • Fang HH. Current activities of varicella vaccine in china. Conference About Quality Control of Live Attenuated Viral Vaccine. 2006 18-19, Shanghai, China
  • WHO. Recommendation for the evaluation of animal cell culture as substrates for manufacture of biological medicine products and for the characterization of cell banksIn: WHO expert committee on biological standardization. Sixty-First Report. 2013 Annex 3. In WHO Technical Report Series No. 978 World Health Organization, Geneva
  • FDA. Guidance for Industry:“Characterization and Qualification of cell Substrates and other biological materials used in the production of viral vaccines for infectious disease Indications”. 2010
  • Sudarshan MK, Bhardwaj S, Mahendra BJ, Sharma H, Sanjay TV, Ashwathnarayana DH, Bilagumba G. An immunogenicity, safety and post-marketing surveillance of a novel adsorbed human diploid cell rabies vaccine (rabivax) in indian subjects. Hum Vaccin 2008; 4 4:275-9; PMID: 18682695; http://dx.doi.org/10.4161/hv.4.4.5588
  • WHO. WHO Expert Consultation on Rabies, First Report, Technical Report Series, 931, 2005, Geneva, Switzerland
  • Tang Q, Li H. Epidemic situation and related factors analysis of rabies in China. Chin J Epidemiol 2005; 26: 223-224
  • http://www.chp.org.cn/cms/business/biological/000064.html
  • Qian H, Yu W, Liu Y, Dou ZY, Du XL, Wang Q. Studies on side effect and immunological effect of CTN-1V stain. China Public Health 2002; 18:946-7
  • He LF, Chen M, Zhang YL, Reng ZY, Hu C, Gao XZ, Zhao ZX, Ma W, Li B, Bai M. Adaption and passage rabies virus strain CTN-1V in human diploid cell strain walvax-2. Prog in Microbiol Immunol 2014;42(5):1-4
  • Yan ZL, Han XJ, Ji YJ, Song ZZ, Yu YX. Studies on the passage and adaptation of a rabies street virus in mice brain and human diploid cell strain. Chin J Microbiol Immunol 1983, 3 5:305-307
  • Dong GM, Liu ZS, Yu YX, Yan ZL, Liu JH. Studies of adaptation and passage on rabies virus (CTN-1) strain in vero cell culture. Prog in Microbiol Immunol 1995; 23 2:82-4
  • Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2 7892:1288-90; PMID: 4139526; http://dx.doi.org/10.1016/S0140-6736(74)90144-5
  • Chen EJ, Ma B, Wei SZ. The study on adaptation of hepatitis a virus YN5 strain in vero cell. Prog in Microbiol Immunol 2003; 31:1-4
  • Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25 585-621; PMID: 13905658; http://dx.doi.org/10.1016/0014-4827(61)90192-6
  • Coburn SP, Leykauf RB. Human Chromosome Analysis Biokit. Burlington, NC: Carolina Biological Supply Co, 1976
  • Kong Y, LI J, An Q, Yang LH, Liu WX, Dong GM. Reverse transcriptase assay of biological products. J Microbiol 2003; 2: 005
  • Chang A, Ostrove JM, Bird RE. Development of an improved product enhanced reverse transcriptase assay. J Virol Methods 1997; 65 1:45-54; PMID: 9128861; http://dx.doi.org/10.1016/S0166-0934(96)02168-4
  • Wiktor TJ, Fernandes MV, Koprowski H. Cultivation of rabies virus in human diploid cell strain WI-38, J Immunol 1964; 93:353-66; PMID: 14218592
  • Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973; 48:535-41; PMID: 4544144
  • Grose C, Brunel PA. Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32°C. Infect Immun 1978; 19 1:199-203; PMID: 203532
  • Rager-Zisman B, Merigan TC. A useful quantitative semi-micromethod for viral plaque assay. Proc Soc Exp Biol Med 1973; 142:1174-9; PMID: 4121080; http://dx.doi.org/10.3181/00379727-142-37202
  • Grose C, Perrotta DM, Brunell PA, Smith GC. Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol 1979; 43 1:15-27; PMID: 225414; http://dx.doi.org/10.1099/0022-1317-43-1-15
  • Wang ZQ, Ma L, Gao H, Dong XG. Propagation of hepatitis a virus in human diploid fibroblast cells. acta virol 1986; 30 6:463-7; PMID: 2881456
  • Wang KQ, Nielsen CM, Vestergaard BF. Isolation and adaptation characteristics of hepatitis a virus in primary african green monkey kidney cells: production of antigen useful for ELISA serology. Intervirology 1985; 24 2:99-107; PMID: 2997078; http://dx.doi.org/10.1159/000149625
  • Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol 1938; 27:493-7